dr.

Sisca Werry
 EPIDEMIOLOGY/BACKGROUND

• Sub family : Orthocoronavirinae, family coronaviridae ; ∅ 120nm

• Cause Respiratory tract infec?on diseases : animals & human
• 7 strain Human coronavirus à SARS-CoV (2003), MERS-CoV (2012, 2015
South Korea outbreak, 2018), SARS-CoV-2 (= 2019-nCoV or novel
coronavirus 2019)
• Transmission : respiratory droplets, direct contact
• Incuba?on period : 2 – 14 days
• Viability : up to 9 days (metal, glass or plas?c) à effec?vely inac?vated
with 62-71% ethanol, 0.5% H2O2, 0.1% sodium hypochlorite in 1 min*
*Journal of Hospital Infec?on
Figure 1. Countries, territories or areas with reported confirmed cases of COVID-19, 12 March 2020
HIGHLIGHTS
•Four new countries/territories/areas (French Polynesia,
Turkey, Honduras and Côte d’Ivoire) have reported cases of
COVID-19 in the past 24 hours.
•The Clinical Unit conJnues to convene clinicians around the
globe, twice weekly by teleconference (COVID-19 Clinical
Network) to share knowledge and experiences from
clinicians caring for COVID-19 paJents and highlight
operaJonal challenges and technical quesJons.
• At the Member States informaJon session held today,
WHO Director-General reiterated that countries should not
give up on stopping the outbreak now that WHO has
characterized it as a pandemic. A shiX from containment to
miJgaJon would be wrong and dangerous. This is a
controllable pandemic.
• Almost 125,000 cases have now been reported to WHO,
from 118 countries and territories. In the past two weeks,
the number of cases reported outside China has increased
almost 13-fold, and the number of affected countries has
almost tripled.
•To save lives we must reduce transmission. That means
finding and isolaJng as many cases as possible, and
quaranJning their closest contacts. Even if you cannot stop
transmission, you can slow it down and protect health
faciliJes, old age homes and other vital areas – but only if
you test all suspected cases.

China
SITUATION IN NUMBERS total and new cases in last 24 hours 80 981 confirmed (26 new) 3173 deaths (11 new)
Globally
125 048 confirmed (6729 new) 4613 deaths (321 new) Outside of China
(from 118 countries & territories) 44 067 confirmed (6703 new) 1440 deaths (310 new)
117 countries/territories/ areas (4 new)
 CLINICAL SYMPTOM COVID-19 PROTOKOL
(KEMENKES RI)
• Fever (Kemenkes : 38℃) ØFeeling unwell with Clinical Symptom à bed
rest à still have symptom : to Clinic /
• Flu/Cough Fasyankes à Screening by Clinic / Fasyankes*
• Sore throat à Hospitalized or OP Treatment (doesn’t have
criteria PDP Covid-19**) or Refer to Designated
• Breathing difficulty Hospital (have all criteria PDP Covid-19)
ØDesignated Hospital : Lab test, patient will be
isolated à if positive : Covid-19 patient, daily
*Pa]ent to Fasyankes with : sample until negative result for 2 consecutive
- Wearing mask days
- Cough/sneeze ethic ØHealthy :
- Don’t use public transporta]on
- With travel history in the past 14 days --> self
**Criteria PDP Covid-19 : monitoring
- Having clinical symptom - Contact history with Covid-19 patient à report
- With travel history within 14 days or to Fasyankes
with contact history
 TRANSMISSION

1. RESPIRATORY DROPLET
- small and usually wet particles that stay in the air for a
short period of time. Particle size > 5 μm (Airborne :
Particle size < 5 μm)
- Droplet travel 1-2 meter before drying out or falling on
the ground à short distance
- Sneeze : 40.000 droplet, cough : 3000 droplet, 5 min
talk: 3000 droplet

2. CONTACT
- Contaminated surfaces / objects
- Touching your mouth, nose or eyes with infected hands
 TREATMENT
DIAGNOSIS and TREATMENT

DIAGNOSE TREATMENT

o Anamnese • An#viral : oseltamivir or Tamiflu

o Chest Rontgen / CT Scan à suppress virus reproduc#on
o Laboratory test : • Symptoma#c treatment : fever,
> DPL, CRP cough, flu
> nasopharyngeal & • Ven#lator : if needed
oropharyngeal swab à is a
must for Pa#ent Under
Surveillance (PDP = Pasien
Dalam Pengawasan)
 PREVENTION

Maintain your
immunity by :
- Having healthy
food
- Additional
vitamin C
THANK YOU,

STAY HEALTHY & ALWAYS BE BLESSED